Sunil Badve
Impact in
- Cancer Research top 0.1%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 0.2%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
Papers in
- Oncology 124
- HER2/EGFR in Cancer Research 29
- Cancer Cells and Metastasis 28
- Cancer Research 103
- Breast Cancer Treatment Studies 69
- Cancer Genomics and Diagnostics 32
- Co-authors
- Harikrishna Nakshatri (37 shared papers)Poornima Bhat‐Nakshatri (16 shared papers)George W. Sledge (39 shared papers)Yesim Gökmen‐Polar (73 shared papers)Frederick L. Baehner (22 shared papers)Edith A. Perez (14 shared papers)Romil Saxena (11 shared papers)Akira Morimiya (13 shared papers)
- Journals
- Journal of Clinical Oncology (47 papers)Cancer Research (23 papers)Modern Pathology (22 papers)Breast Cancer Research and Treatment (20 papers)Clinical Cancer Research (11 papers)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Sunil Badve
315 papers receiving 14.8k citations
Sunil Badve's Hit Papers
Peers
Comparison fields: 5 of 167
- Cancer Research 4.0k
- Oncology 5.4k
- Molecular Biology 5.1k
- Pathology and Forensic Medicine 1.2k
- Hepatology 488
Countries citing papers authored by Sunil Badve
This map shows the geographic impact of Sunil Badve's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sunil Badve with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sunil Badve more than expected).
Fields of papers citing papers by Sunil Badve
This network shows the impact of papers produced by Sunil Badve. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sunil Badve. The network helps show where Sunil Badve may publish in the future.
Co-authors
The 25 scholars most cited alongside Sunil Badve, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 326 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199 Hit paper breakdown → | 2014 | 979 |
| 2 | CD44+/CD24-breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis Hit paper breakdown → | 2006 | 831 |
| 3 | Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation Hit paper breakdown → | 2000 | 804 |
| 4 | Breast cancer prognostic classification in the molecular era: the role of histological grade Hit paper breakdown → | 2010 | 690 |
| 5 | A Cellular Trojan Horse for Delivery of Therapeutic Nanoparticles into Tumors Hit paper breakdown → | 2007 | 528 |
| 6 | Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists Hit paper breakdown → | 2010 | 527 |
| 7 | NF-κB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2 Hit paper breakdown → | 2006 | 516 |
| 8 | Association of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 Genetic Polymorphisms With Outcome in a Trial of Paclitaxel Compared With Paclitaxel Plus Bevacizumab in Advanced Breast Cancer: ECOG 2100 Hit paper breakdown → | 2008 | 502 |
| 9 | 2008 | 269 | |
| 10 | 2005 | 251 | |
| 11 | 2007 | 202 | |
| 12 | 2015 | 192 | |
| 13 | 2015 | 188 | |
| 14 | 2008 | 187 | |
| 15 | 2015 | 179 | |
| 16 | 2014 | 179 | |
| 17 | 2002 | 171 | |
| 18 | 2011 | 168 | |
| 19 | 2009 | 168 | |
| 20 | 2010 | 150 |
About Sunil Badve
Sunil Badve is a scholar working on Oncology, Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 326 papers that have together received 15.3k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (69 papers), Cancer Genomics and Diagnostics (32 papers), HER2/EGFR in Cancer Research (29 papers), Cancer Cells and Metastasis (28 papers), Breast Lesions and Carcinomas (26 papers), Myasthenia Gravis and Thymoma (24 papers), Estrogen and related hormone effects (19 papers) and Advanced Breast Cancer Therapies (19 papers). The work is most often cited by research in Cancer Research (4.0k citations), Oncology (5.4k citations), Molecular Biology (5.1k citations), Pathology and Forensic Medicine (1.2k citations) and Hepatology (488 citations). Sunil Badve has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Harikrishna Nakshatri, Poornima Bhat‐Nakshatri, George W. Sledge, Yesim Gökmen‐Polar, Frederick L. Baehner, Edith A. Perez, Romil Saxena, Akira Morimiya, Nancy E. Davidson and Susan E. Clare. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Modern Pathology, Breast Cancer Research and Treatment and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.